HR 9421In Committee
To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.
Introduced June 24, 2026
Summary
Timeline
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
See how this bill affects you
Enter your details to get a personalized impact estimate.
Check your impact